Antiplatelet cilostazol, an inhibitor of type III phosphodiesterase, improves swallowing function in patients with a history of stroke

Journal of the American Geriatrics Society

Volumn 56, Issue 6, 2008, Pages 1153-1154

  Teramoto, Shinji ^a   Yamamoto, Hiroshi ^a   Yamaguchi, Yasuhiro ^a   Ishii, Masaki ^a   Hibi, Shinichiro ^a   Kume, Haruki ^b   Ouchi, Yasuyoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Department of Urology ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; PHOSPHODIESTERASE III; PLACEBO;

CLINICAL EXAMINATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; DYSPHAGIA; HUMAN; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEIOTROPY; PNEUMONIA; RADIOIMMUNOASSAY; SPUTUM ANALYSIS; STROKE; SWALLOWING;

AGED; ASPIRIN; CROSS-OVER STUDIES; DEGLUTITION DISORDERS; DOUBLE-BLIND METHOD; HUMANS; MALE; PHOSPHODIESTERASE INHIBITORS; SALIVA; STROKE; SUBSTANCE P; TETRAZOLES;

EID: 44649109627     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2008.01703.x     Document Type: Letter

References (10)

1. Sellars C, Bowie L, Bagg J et al. Risk factors for chest infection in acute stroke: A prospective cohort study. Stroke 2007 38 : 2284 2291.
2. Yamaya M, Yanai M, Ohrui T et al. Antithrombotic therapy for prevention of pneumonia. J Am Geriatr Soc 2001 49 : 687 688.
3. Shinohara Y for the CSPS group. Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage. Cerebrovasc Dis 2006 22 : 57 60.
4. Teramoto S, Matsuse T, Fukuchi Y et al. Simple two-step swallowing provocation test for elderly patients with aspiration pneumonia. Lancet 1999 353 : 1243 1243.
5. Teramoto S, Fukuchi Y. Detection of aspiration and swallowing disorder in older stroke patients: Simple swallowing provocation test versus water swallowing test. Arch Phys Med Rehabil 2000 81 : 1517 1519.
6. Nakagawa T, Ohrui T, Sekizawa K et al. Sputum substance P in aspiration pneumonia. Lancet 1995 345 : 1447.
7. Arai T, Yoshimi N, Fujiwara H et al. Serum substance P concentrations and silent aspiration in elderly patients with stroke. Neurology 2003 61 : 1625 1626.
8. Joyce TJ, Yood RA, Carraway RE. Quantification of substance-P and its metabolites in plasma and synovial fluid from patients with arthritis. J Clin Endocrinol Metab 1993 77 : 632 637.
9. Watanabe T, Zhang N, Liu M et al. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion. Stroke 2006 37 : 1539 1545.
10. Yamada K, Inoue H, Kida S et al. Involvement of camp response element-binding protein activation in salivary secretion. Pathobiology 2006 73 : 1 7.